NYSE:TAK

Takeda Pharmaceutical Company Stock Insider Trading

Healthcare > Drug Manufacturers - Specialty & Generic

Buy TAK

*Your capital is at risk

$17.09

-0.160 (-0.93%)

At Close: Jul 31, 2026

Takeda Pharmaceutical Company Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 1.65M and sold 25.4K TAK shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	100.00
● Buy	1.65M shares
● Sell	25.4K shares
93% Buy Activity Moderate Positive Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jul 01, 2026 Buy	Tax Obligation Award A-Award	Stoffels Paulus Director	Director	1 307 Value: $20.8K
Jul 01, 2026 Buy	Tax Obligation Award A-Award	Kimura Koichiro Director	Director	1 937 Value: $30.9K
Jul 01, 2026 Buy	Ordinary Shares A-Award	Kimura Koichiro Director	Director	1 800 Value: $28.7K
Jul 01, 2026 Buy	Ordinary Shares A-Award	Tsusaka Miki Director	Director	1 800 Value: $28.7K
Jul 01, 2026 Buy	Tax Obligation Award A-Award	Tsusaka Miki Director	Director	1 937 Value: $30.9K
Jul 01, 2026 Buy	Ordinary Shares A-Award	Miyabashira Asuka President, Japan Pharma B.u.	CEO / President	1 500 Value: $23.9K
Jul 01, 2026 Buy	Tax Obligation Award A-Award	Miyabashira Asuka President, Japan Pharma B.u.	CEO / President	664 Value: $10.6K
Jul 01, 2026 Buy	Tax Obligation Award A-Award	Miyabashira Asuka President, Japan Pharma B.u.	CEO / President	664 Value: $10.6K
Jul 01, 2026 Buy	Tax Obligation Award A-Award	Miyabashira Asuka President, Japan Pharma B.u.	CEO / President	666 Value: $10.6K
Jul 01, 2026 Buy	Ordinary Shares A-Award	Furuta Milano Chief Financial Officer	C-Suite Officer	12 300 Value: $196.2K
Jul 01, 2026 Buy	Tax Obligation Award A-Award	Furuta Milano Chief Financial Officer	C-Suite Officer	4 288 Value: $68.4K
Jul 01, 2026 Buy	Tax Obligation Award A-Award	Furuta Milano Chief Financial Officer	C-Suite Officer	4 288 Value: $68.4K
Jul 01, 2026 Buy	Tax Obligation Award A-Award	Furuta Milano Chief Financial Officer	C-Suite Officer	4 288 Value: $68.4K
Jul 01, 2026 Buy	American Depositary Shares A-Award	Platford Giles Richard President, Ibu	CEO / President	49 558 Value: $790.5K
Jul 01, 2026 Buy	American Depositary Shares A-Award	Smoter Jennifer Marie Chief Comm. & Gov. Officer	Officer	18 808 Value: $300.0K
Jul 01, 2026 Buy	American Depositary Shares A-Award	Ibrahim Ramy Riad Ahmed President, Pdt Bu	CEO / President	25 078 Value: $400.0K
Jul 01, 2026 Buy	American Depositary Shares A-Award	Greenway Nicola Deidre Petal Chief Human Resources Officer	Officer	22 570 Value: $360.0K
Jul 01, 2026 Buy	American Depositary Shares A-Award	Farajallah Awny Samaan Botros Chief Medical Officer	Officer	17 554 Value: $280.0K
Jul 01, 2026 Buy	American Depositary Shares A-Award	Furney Natalie Anne Marie Global General Counsel	Officer	43 886 Value: $700.0K
Jul 01, 2026 Buy	American Depositary Shares A-Award	Pacheco Rhonda Janice President, U.s. Business Unit	CEO / President	50 156 Value: $800.0K
Jul 01, 2026 Buy	American Depositary Shares A-Award	Pignagnoli Agosti Marcello Head, Strat. & Port. Dev.	Officer	27 586 Value: $440.0K
Jul 01, 2026 Buy	American Depositary Shares A-Award	Ricci Gabriele Chief Data & Tech. Officer	Officer	37 616 Value: $600.0K
Jul 01, 2026 Buy	American Depositary Shares A-Award	Shannon Elaine Mary Pres., Global Supply & Quality	Officer	30 094 Value: $480.0K
Jul 01, 2026 Buy	American Depositary Shares A-Award	Duprey Lauren Rusckowski Chief Transformation Officer	Officer	45 140 Value: $720.0K
Jul 01, 2026 Buy	American Depositary Shares A-Award	Bitetti Teresa Marie President, Obu	CEO / President	43 886 Value: $700.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT TAKEDA PHARMACEUTICAL COMPANY LIMITED

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Reves...

Read Full Profile Here